ResearchClinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay
ResearchDeveloping a Virtual Research Environment in the Parkinson's Progression Markers Initiative: myPPMI
ResearchProdromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy
ResearchHow PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein Disease
ResearchExpanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI
ResearchIdentification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
ResearchStable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study
ResearchImproving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study (AT-HOME PD2)
ResearchEnvironmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunities
ResearchSelf-perceived life course sleep duration trajectories and risk and age at onset of Parkinson's disease